Patients with mental or physical illness who participated in an exercise intervention had fewer suicide attempts, although there was no reduction in suicidal ideation.
Single-dose synthetic psilocybin improves the core symptoms of treatment-resistant depression, while other frequently measured parameters only contribute noise to the outcome, phase 2 data show.
For older patients with resistant depression who fail to respond to antidepressants, the addition of atypical antipsychotic aripiprazole is superior to switching antidepressants, new research suggests.